Form ARS Ultragenyx Pharmaceutica For: Dec 31
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ultragenyx Pharma (RARE) PT Raised to $83 at Canaccord
- CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy
- Honoring the Past, Building the Future: A Conversation With Ryan Rogers, Chief Executive Officer of Mary Kay Inc.
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
